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Article
Multimorbidity and mortality: A 15-year
longitudinal registry-based nationwide
Danish population study
TG Willadsen1 , V Siersma1, DR Nicolaisdo´ttir1, R Køster-Rasmussen1,
DE Jarbøl2, S Reventlow1, SW Mercer3 and N de Fine Olivarius1
Abstract
Background: Knowledge about prevalent and deadly combinations of multimorbidity is needed. Objective: To
determine the nationwide prevalence of multimorbidity and estimate mortality for the most prevalent combinations of
one to five diagnosis groups. Furthermore, to assess the excess mortality of the combination of two groups compared to
the product of mortality associated with the single groups. Design: A prospective cohort study using Danish registries
and including 3.986.209 people aged18 years on 1 January, 2000. Multimorbidity was defined as having diagnoses from at
least 2 of 10 diagnosis groups: lung, musculoskeletal, endocrine, mental, cancer, neurological, gastrointestinal, cardio-
vascular, kidney, and sensory organs. Logistic regression (odds ratios, ORs) and ratio of ORs (ROR) were used to study
mortality and excess mortality. Results: Prevalence of multimorbidity was 7.1% in the Danish population. The most
prevalent combination was the musculoskeletal–cardiovascular (0.4%), which had double the mortality (OR, 2.03)
compared to persons not belonging to any of the diagnosis groups but showed no excess mortality (ROR, 0.97). The
neurological–cancer combination had the highest mortality (OR, 6.35), was less prevalent (0.07%), and had no excess
mortality (ROR, 0.94). Cardiovascular–lung was moderately prevalent (0.2%), had high mortality (OR, 5.75), and had
excess mortality (ROR, 1.18). Endocrine–kidney had high excess mortality (ROR, 1.81) and cancer–mental had low excess
mortality (ROR, 0.66). Mortality increased with the number of groups. Conclusions: All combinations had increased
mortality risk with some of them having up to a six-fold increased risk. Mortality increased with the number of diagnosis
groups. Most combinations did not increase mortality above that expected, that is, were additive rather than synergistic.
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Introduction
The number of people living with multimorbidity is high,1
and the prevalence has risen considerably in high-income
countries during the last decades.2 Multimorbidity is most
often defined as the co-occurrence of two or more chronic
conditions in a person.3 However, there is no consensus
about the definition4,5 that explains most of the observed
differences in prevalence estimates.6,7 Multimorbidity is
associated with increased health-care use with higher costs
as a consequence.8 Patients with multimorbidity report
lower quality of life,9,10 more mental symptoms,7 and expe-
rience more fragmented care.11 Mortality increases with
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both number and certain combinations of diseases.12–14
Despite ongoing research on patterns of multimorbid-
ity,15,16 health-care systems are still better prepared for
handling single diseases than their combinations because
of their focus on specialism rather than generalism.17
Patients with multimorbidity require a comprehensive
care approach, and treatments may depend on the specific
combinations of diseases.18 Therefore, in the present study,
multimorbidity was defined by combinations of diagnoses
from at least 2 of 10 groups of diagnoses. Knowledge about
relevant combinations, that is, the most prevalent and their
related mortality, may guide us regarding how to intervene.
The association between multimorbidity and mortality is
known.14 There exist some longitudinal studies exploring
mortality in relation to multimorbidity with long, that is, 10
years or longer12,19,20 and shorter,13,21,22 follow-up times.
One of the studies explored the most prevalent and the
most lethal combinations of two to five diseases, respec-
tively,19 and one explored specific lethal combinations of
two and three conditions.13 However, all these studies
included persons aged >65 years with the last study only
including a limited number of persons aged 85 years or
older.13 Multimorbidity is not just an issue for older peo-
ple7 and to be able to intervene efficiently a focus on the
general population is necessary. This study investigates
relevant combinations of multimorbidity, that is, preva-
lent combinations associated with high mortality. The
mortality in relation to the most prevalent specific combi-
nations of one to five organizationally and manageably
similar groups of diagnoses, in an entire adult population,
will be identified.
Objectives
This study has four aims: (1) to identify the most prevalent
combinations (of one to five diagnosis groups) of multi-
morbidity; (2) to find among all combinations of two diag-
nosis groups the combinations with highest mortality; (3) to
assess the excess mortality from having a combination of
two diagnosis groups, compared to the product of the mor-
tality when the same diagnosis groups appear individually;
and (4) to estimate the mortality associated with the most
prevalent combinations of three, four, and five diagnosis
groups.
Material and methods
Study design and population
This study is a historical prospective cohort study in Den-
mark including 3.986.209 people aged 18 years and alive
at baseline on 1 January, 2000 (Figure 1). The cohort was
created based on information from the Danish Civil Regis-
tration System (CRS)23 and followed for 15 years until 31
December, 2014. Background characteristics of the cohort
were identified at baseline: age, sex, socioeconomic status
(family income, highest completed education, work status,
and assets), degree of urbanization, and cohabitation status.
The level of multimorbidity was estimated at baseline by
collecting information from the national health registries
on all diagnoses related to hospital admissions or hospital
outpatient clinic contacts 10 years before baseline (1 Jan-
uary, 1990, until 31 December, 1999). Our outcome was
15-year all-cause mortality. Patients who migrated or
Sample from the Danish Civil Registration System
Population alive and aged ≥18 years on 1 January 2000
(n=4 172 941)
Eligible for the register study
(n=3 986 209)
End of 15-year follow-up
(n=3 092 063)
Excluded at baseline
Emigrated or immigrated during ten
years prior to year 2000
(n=186 732)
Censored during follow-up 2000-2014
Emigrated (n=76 414)
Disappeared (n=15 543)
Dead (n=802 189)
Figure 1. The population cohort through study.
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disappeared during the 10 years before baseline were
excluded (Figure 1).
Nationwide registries
In Denmark, all live born children and new residents get a
unique personal identification number stored in CRS. CRS
provides information on vital status, address, family con-
nections, emigration, and so on.23 The personal identifica-
tion number can be used to link information from all
Danish registries on an individual level. Since registration
in CRS is required by Danish law and the register is used
continuously for administrative purposes, is updated
weekly, and errors are corrected continuously, the register
is believed to contain accurate information of high
quality.23
Information about diagnoses were obtained from three
registers: the Danish National Patient Register (NPR),24 the
Danish Cancer Registry (CR),25 and the Danish Psychiatric
Central Research Register (PCRR).26 NPR is believed to be
complete at least after year 2000 where the codes became
the payment basis for hospitals.24 However, outpatient care
and emergency admissions were first included in 1995. In
NPR, diagnostic information is registered as International
Classification of Diseases, 10th edition (ICD-10) and the
earlier version 8th edition (ICD-8).27 The shift between
versions happened in 1994. CR includes data on all incident
cancers in Denmark since 1943, and CR has used ICD-10
codes since 1978.25 In Denmark, patients with mental ill-
nesses and in need of secondary care are treated at public
hospitals and registered in PCRR with ICD codes as in
NPR.26 To collect information on socioeconomic status,
Statistics Denmark’s registers on income,28 education,29
work status,30 and assets28 were used.
The study was based on anonymized administrative reg-
ister data, which is why neither collection of informed
consent from the involved persons nor approval from the
Ethics Committee was needed. The study was approved by
The Danish Data Protection Agency, The Danish Health
Data Authority, and Statistics Denmark.
Definition of multimorbidity
The definition of multimorbidity was based on diagnoses
organized in 10 groups where the groups to some extent
share treatments, clinical picture, or organization of health
care: lung, musculoskeletal, endocrine, mental, cancer,
neurological, gastrointestinal, cardiovascular, genitourin-
ary, and sensory organs, with each group containing several
diagnoses (Online Supplemental Material 1). Multimorbid-
ity was defined as having diagnoses from two or more
different groups. The diagnoses included within the 10
groups were selected based on clinical relevance, defini-
tions used in earlier work on multimorbidity,7,31 and rec-
ommendations from systematic reviews.4,6,32,33 Moreover,
by grouping diagnoses instead of handling them as singles,
complexity is better embraced, since it is organizationally
and physiologically more complex if patients suffer from
diagnoses with differences in treatments and organization
of health care.
Statistical analyses
Prevalence of multimorbidity is presented as numbers and
percentages of the whole population. The association
between 15-year mortality and multimorbidity (combina-
tions of one to five mutually exclusive diagnosis groups of
these 10 groups), compared with those not belonging to any
of the groups, is assessed by odds ratios (ORs) from multi-
variable logistic regression (with every combination giving
an OR) adjusted for age, sex, socioeconomic status
(income, highest completed education, work status, and
assets), degree of urbanization, and cohabitation status
(incorporated in the analyses in the categorizations shown
in Table 1). The large cohort made us able to look at all
possible combinations of two diagnosis groups (45 in total).
However, the expected small numbers of patients in some
groups made us solely looking at the five most prevalent
combinations for three, four, and five diagnosis groups,
respectively.
A relative excess mortality for a combination of diag-
noses from diagnosis groups A and B was calculated as a
ratio of ORs (ROR) ¼ ORAþB/(ORAORB), that is, the
mortality increases associated with having diagnoses from
both diagnosis groups A and B (a potential interaction)
relative to the product of the mortality increases associated
with having a diagnose from group A but not from group B,
or vice versa. p-Values were calculated for all interactions.
At the end of the follow–up, the group that emigrated or
disappeared was considered to be alive at a 15-year follow-
up. In sensitivity analyses, this group was considered dead
at a 15-year follow-up. Analyses were performed using
SAS, version 94 (SAS Institute Inc., Cary, North Carolina,
USA).
Results
At baseline, the population consisted of 4.172.941 individ-
uals (49.1% men and 50.9% women) and during follow-up
802.189 died (Figure 1).
The prevalence of multimorbidity in the Danish popu-
lation was 7.1% at baseline (year 2000), increasing from
1.7% in those aged 18–39 years to 29.1% among those aged
80þ (Table 1). Multimorbidity was relatively more preva-
lent in females, those living alone, and those with low
socioeconomic status.
Overall, musculoskeletal and cardiovascular diagnosis
groups were the most frequent individual groups with a
prevalence of 7.4% and 5.5%, respectively (Online Supple-
mental Material 2). The musculoskeletal–cardiovascular
combination was the most prevalent pair of diagnosis
groups, occurring in 16.001 people (0.4%) (Table 2, Figure 2,
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and Online Supplemental Material 3). The number of
patients dropped rapidly by increasing the number of diag-
nosis groups. Of notice, the musculoskeletal and the cardi-
ovascular diagnosis groups were included in almost all the
five most common combinations of three, four, and five
diagnosis groups (Table 2).
Figure 2 illustrates prevalence, mortality (OR), and rela-
tive excess mortality (ROR) for all possible combinations
of two diagnosis groups (pairs). All combinations had
increased mortality compared with individuals without
diagnoses from any of the 10 diagnosis groups. Pairs con-
taining a musculoskeletal diagnosis were generally associ-
ated with the lowest mortality with none of the
combinations having an OR exceeding three. Combinations
including lung diagnoses, on the other hand, had a three-
fold increased mortality for all combinations with the
exception of those including musculoskeletal diagnoses
(Figure 2).
Table 1. Baseline characteristics of the Danish population by number of diagnosis groups.
Baselinea characteristics
Zero diagnosis
groupsb
N ¼ 2,943,205
(73.83%)
One diagnosis
group
N ¼ 759,182
(19.05%)
Two diagnosis
groups
N ¼ 206,096
(5.17%)
Three
diagnosis
groups N ¼
58,454 (1.47%)
Four þ diagnosis
groups
N ¼ 19,272
(0.48%)
Total
N ¼ 3,986,209
(100.00%)
n % n % n % n % n % n %
Sex
Male 1,486,037 50.49 344,667 45.40 91,189 44.25 25,252 43.20 7972 41.37 1,955,117 49.05
Age, years
18–39 1,301,845 44.23 186,928 24.62 23,050 11.18 2897 4.96 462 2.40 1,515,182 38.01
40–64 1,251,062 42.51 336,354 44.30 77,692 37.70 17,510 29.96 4750 24.65 1,687,368 42.33
65–79 313,398 10.65 165,386 21.78 66,501 32.27 22,362 38.26 8004 41.53 575,651 14.44
80þ 76,900 2.61 70,514 9.29 38,853 18.85 15,685 26.83 6056 31.42 208,008 5.22
Education
None 135,350 4.60 90,996 11.99 46,079 22.36 18,026 30.84 6812 35.35 297,263 7.46
Primary school 949,414 32.26 293,242 38.63 84,190 40.85 23,659 40.47 7827 40.61 1,358,332 34.08
Secondary schoolc 1,250,687 42.49 257,520 33.92 54,130 26.26 12,342 21.11 3500 18.16 1,578,179 39.59
Higher educationd 607,754 20.65 117,424 15.47 21,697 10.53 4427 7.57 1133 5.88 752,435 18.88
Incomee
0–99,999 486,006 16.51 166,757 21.97 62,830 30.49 22,221 38.01 8695 45.12 746,509 18.73
100,000–149,999 918,428 31.21 282,951 37.27 84,459 40.98 24,335 41.63 7866 40.82 1,318,039 33.06
150,000–199,999 870,610 29.58 179,558 23.65 35,736 17.34 7821 13.38 1861 9.66 1,095,586 27.48
200,000þ 668,161 22.70 129,916 17.11 23,071 11.19 4077 6.97 850 4.41 826,075 20.72
Working status
Working 2,065,190 70.17 331,180 43.62 44,154 21.42 5548 9.49 727 3.77 2,446,799 61.38
Out of workforcef 416,188 14.14 171,745 22.62 52,779 25.61 14,436 24.70 4557 23.65 659,705 16.55
Pensioners 461,827 15.69 256,257 33.75 109,163 52.97 38,470 65.81 13,988 72.58 879,705 22.07
Assetsg
<0 1,096,792 37.27 253,763 33.43 62,613 30.38 17,821 30.49 6626 34.38 1,437,615 36.06
0–149,999 873,710 29.69 232,751 30.66 69,031 33.49 21,054 36.02 7220 37.46 1,203,766 30.20
150,000þ 972,703 33.05 272,668 35.92 74,452 36.12 19,579 33.49 5426 28.15 1,344,828 33.74
Urbanization degreeh
Rural 1,012,167 34.39 261,615 34.46 71,130 34.51 19,411 33.21 6038 31.33 1,370,361 34.38
Small town 1,077,357 36.60 272,407 35.88 71,506 34.70 19,611 33.55 6099 31.65 1,446,980 36.30
Capital city 853,681 29.01 225,160 29.66 63,460 30.79 19,432 33.24 7135 37.02 1,168,868 29.32
Cohabiting
Yes 2,051,871 69.72 466,553 61.45 108,255 52.53 26,423 45.20 7541 39.13 2,660,643 66.75
a1 January, 2000.
bPresented as dichotomous variables in numbers (n) and percentages (%). No multimorbidity ¼ 0 or 1 diagnosis group, multimorbidity ¼ 2, 3 and 4
diagnosis groups.
cSecondary school: secondary school, high school and higher level vocational studies.
dHigher educations: short and medium higher education or college diploma, university degree (bachelor or master), doctoral degree.
eIncome: divided in quartiles, yearly income of the family in Danish kroner.
fOut of workforce: unemployed, student, apprentice or intern, or incapacity benefits.
gAssets: divided in tertiles, presented in Danish kroner, including stocks, bonds, savings in banks and housing, within and outside Denmark.
hRural: At least 50% of the population in the municipality lives in a thinly populated area. Small town: intermediate density area. Less than 50% of the
population lives in a densely populated area and less than 50% of the population lives in a thinly populated area. Capital: At least 50% of the population
lives in a densely populated area.
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Furthermore, pairs including diagnoses from neurologi-
cal, cancer, lung, cardiovascular, and mental diagnosis
groups had the highest mortality, with the neurological–
cancer combination having the highest OR (6.35; 95% con-
fidence interval (CI): 5.71–7.06) followed by neurological–
endocrine (5.94; 95% CI: 5.42–6.50) and cardiovascular-
lung (5.75; 95% CI: 5.42–6.10) (Online Supplemental
Material 3). Men having diagnoses from either the endo
or the cancer diagnosis groups had a doubled mortality risk
compared to women. For the oldest age group, a high mor-
tality risk was associated with having a diagnosis from the
mental diagnosis group (Online Supplemental Material 4).
Relative excess mortality was highest for the combina-
tion of kidney–endocrine with 81% increased mortality.
The mental–cancer combination, on the other hand, had a
34% reduced mortality compared with the product of the
risks when these diagnosis groups appeared singly in two
individuals (Figure 2 and Online Supplemental Material 5).
Mortality increased rapidly with the number of diagno-
sis groups, also after adjustment. The combination of five
groups including musculoskeletal, endocrine, mental, neu-
rological, and cardiovascular had by far the highest mor-
tality (Table 3). The sensitivity analyses did not change the
main results (Online Supplemental Material 6).
Discussion
We examined the prevalence of different multimorbidity
combinations and the associated mortality in a nationwide
Table 2. The five most prevalent combinations of one, two, three, four, and five diagnosis groups, respectively.a
Rank One diagnosis groupb Two diagnosis groups Three diagnosis groups Four diagnosis groups Five diagnosis groups
1 MUSCULOSKELETAL MUSCULOSKELETAL
þ HEART
MUSCULOSKELETAL þ
HEART þ SENSORY
LUNG þ
MUSCULOSKELETAL
þ HEART þ
SENSORY
MUSCULOSKELETAL þ
ENDO þ NEURO þ
HEART þ SENSORY
181,159 (4.60%) 16,001 (0.40%) 2772 (0.07%) 480 (0.01%) 124 (0.00%)
2 MENTAL MUSCULOSKELETAL
þ SENSORY
LUNG þ
MUSCULOSKELETAL
þ HEART
MUSCULOSKELETAL þ
ENDO þ HEART þ
SENSORY
LUNG þ
MUSCULOSKELETAL
þ ENDO þ HEART þ
SENSORY
114,479 (2.90%) 12,109 (0.30%) 2240 (0.06%) 471 (0.01%) 107 (0.00%)
3 HEART HEART þ SENSORY MUSCULOSKELETAL þ
ENDO þ HEART
MUSCULOSKELETAL þ
NEURO þ HEART þ
SENSORY
MUSCULOSKELETAL þ
ENDO þ MENTAL þ
NEURO þ HEART
98,103 (2.50%) 11,118 (0.30%) 2191 (0.05%) 449 (0.01%) 85 (0.00%)
4 SENSORY ENDO þ HEART MUSCULOSKELETAL þ
NEURO þ HEART
LUNG þ
MUSCULOSKELETAL
þ ENDO þ HEART
LUNG þ
MUSCULOSKELETAL
þ ENDO þ GASTRO
þ HEART
77,589 (2.00%) 10,890 (0.30%) 1961 (0.05%) 415 (0.01%) 68 (0.00%)
5 CANCER MUSCULOSKELETAL
þ MENTAL
ENDO þ NEURO þ
HEART
MUSCULOSKELETAL þ
ENDO þ NEURO þ
HEART
ENDO þ MENTAL þ
NEURO þ HEART þ
SENSORY
72,296 (1.80%) 10,737 (0.30%) 1902 (0.05%) 388 (0.01%) 67 (0.00%)
LUNG: lung diagnoses; MUSCULOSKELETAL: musculoskeletal diagnoses; ENDO: endocrine diagnoses; MENTAL: mental diagnoses; CANCER: cancer
diagnoses; NEURO: neurological diagnoses; GASTRO: gastrointestinal diagnoses; HEART: cardiovascular diagnoses; KIDNEY: genitourinary diagnoses;
SENSORY: sensory organ diagnoses.
aValues are presented as numbers (N) and percentages (%).
bAt baseline, January 1, 2000.
Figure 2. Prevalence (size of the circles), mortality (grey scale),
and interaction or relative excess mortality or the ROR (border
color of the circles) for all possible pairs of multimorbidity
(adjusted for age, sex, socioeconomic status, cohabitation status,
and degree of urbanization). ROR: ratio of odds ratio.
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Danish population sample. The musculoskeletal–cardiovas-
cular combination was the most prevalent, cancer–neurolo-
gical had the highest mortality, and the lung–cardiovascular
combination was both prevalent and lethal. Pairs including
musculoskeletal diagnoses had a relatively low mortality.
Some pairs interacted and had different mortalities when
in combination, compared to the product of the individual
mortalities. Prevalence dropped rapidly and mortality
increased steeply with the number of diagnosis groups.
Prevalence of multimorbidity
By using a new definition, the prevalence of multimorbid-
ity in the Danish population was 7.1%. In earlier studies,
the prevalence of multimorbidity has been found to vary
from 3.5% to 98.5% depending on age group and set-
ting.6,16 A Danish study using register data, but defining
multimorbidity by counting diagnoses from a list of 39
conditions, estimated the prevalence to be 20% for people
having two or three diagnoses and 9% for those having four
or more.34 In line with our results, several studies have
found increasing prevalence with age6,7,16,35 and higher
rates in women.16,36 The relatively low prevalence in the
present study is mainly explained by (1) our definition of
multimorbidity with the use of diagnosis groups, instead of
single diagnoses; (2) our use of register data from second-
ary care, instead of data from primary care; and (3) our
population, including adults aged 18 years and not only
older people.4–6
Our finding of musculoskeletal and cardiovascular as the
most prevalent diagnosis groups, both as singles and in com-
bination, is in line with earlier research, where cardiovascu-
lar, metabolic, and musculoskeletal clusters are found to be
the most prevalent single clusters in all age groups.37 Addi-
tionally, hypertension and osteoarthritis has been found to be
the most frequent combination,16 and also the combination
of metabolic (including cardiovascular) and musculoskeletal
conditions is common, where lower back pain is the condi-
tion most likely to occur with other conditions.38 A systema-
tic review found depression most likely to co-occur with
other conditions and found the combinations of depression
and arthritis and depression and diabetes to be the second
and the third most common diagnosis pairs, respectively.39
We did not find the mental–musculoskeletal and mental–
endocrine combinations in the top three, maybe because
we used secondary care diagnoses without information about
less serious mental illnesses treated solely in primary care.
Mortality and relative excess mortality
We found the cancer–neurological combination to be the
most hazardous, followed by neurological–endocrine and
cardiovascular–lung. Moreover, we found mental diag-
noses to be generally associated with higher mortality.
Cardiovascular diseases in combination with either
Table 3. Prevalence and OR of mortality for the five most prevalent combinations of three, four, and five diagnosis groups.
Rank Number and type of diagnosis groups Totala
Unadjusted
OR (95% CI)b
Adjusted
OR (95% CI)b,c
Combinations of three
1 MUSCULOSKELETAL–HEART–SENSORY 2772 (0.07%) 30.6 (27.8–33.7) 2.52 (2.24–2.83)
2 LUNG–MUSCULOSKELETAL–HEART 2240 (0.06%) 28.3 (25.5–31.5) 5.58 (4.94–6.31)
3 MUSCULOSKELETAL–ENDO–HEART 2191 (0.05%) 19.2 (17.5–21.1) 3.81 (3.40–4.27)
4 MUSCULOSKELETAL–NEURO–HEART 1961 (0.05%) 23.7 (21.3–26.4) 4.12 (3.62–4.70)
5 ENDO–NEURO–HEART 1902 (0.05%) 46.3 (40.4–52.9) 8.68 (7.45–10.1)
Combinations of four
1 LUNG–MUSCULOSKELETAL–HEART–SENSORY 480 (0.01%) 98.6 (68.5–142) 10.1 (6.85–15.0)
2 MUSCULOSKELETAL–ENDO–HEART–SENSORY 471 (0.01%) 52.6 (39.6–69.8) 4.91 (3.52–6.86)
3 MUSCULOSKELETAL–NEURO–HEART–SENSORY 449 (0.01%) 73.6 (52.8–103) 5.25 (3.58–7.68)
4 LUNG–MUSCULOSKELETAL–ENDO–HEART 415 (0.01%) 48.6 (36.3–65.1) 9.70 (6.99–13.5)
5 MUSCULOSKELETAL–ENDO–NEURO–HEART 388 (0.01%) 53.2 (38.9–72.9) 7.57 (5.34–10.7)
Combinations of five
1 MUSCULOSKELETAL–ENDO–NEURO–HEART–SENSORY 124 (0.00%) 275 (87.3–863) 26.0 (7.90–85.6)
2 LUNG–MUSCULOSKELETAL–ENDO–HEART–SENSORY 107 (0.00%) 139 (56.6–341) 15.2 (5.72–40.4)
3 MUSCULOSKELETAL–ENDO–MENTAL–NEURO–HEART 85 (0.00%) 572 (79.6–4108) 76.4 (10.3–565)
4 LUNG–MUSCULOSKELETAL–ENDO–KIDNEY–HEART 68 (0.00%) 81.7 (19.3–346) 12.7 (2.72–59.1)
5 ENDO–MENTAL–NEURO–HEART–SENSORY 67 (0.00%) (—) (—)
OR: odds ratio; CI: confidence interval; LUNG: lung diagnoses; MUSCULOSKELETAL: musculoskeletal diagnoses; ENDO: endocrine diagnoses;
MENTAL: mental diagnoses; CANCER: cancer diagnoses; NEURO: neurological diagnoses; HEART: cardiovascular diagnoses; KIDNEY: genitourinary
diagnoses; SENSORY: sensory organ diagnoses.
aNumbers (n) and percentages (%) are presented.
bOdds ratios for mortality for all combinations of three, four, and five diagnosis groups compared to persons without any diagnose included in the 10
groups, calculated with logistic regression, presented with 95% CIs.
cAdjusted for age, sex, socioeconomic status (education, income, working status, and assets), and degree of urbanization and cohabitation status.
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diabetes or mental problems have been shown to be both
frequent and highly mortal.19 Perhaps, neurological and
cognitive functions are required to understand and cope
with symptoms as well as health advices. Furthermore,
neurological diagnoses like Parkinson’s disease and cere-
brovascular diseases are strongly related to frailty indica-
tors, for example, geriatric syndromes.40 The
cardiovascular–lung group may contain individuals who
share lifestyle risk factors for developing chronic condi-
tions like, for example, smoking. In this study, pairs
including musculoskeletal diagnoses had the lowest mor-
tality, which is in line with earlier work where arthritis
was associated with lower risk of death.19
The kidney–endocrine combination, followed by gastro-
intestinal–mental, had the highest relative excess mortality,
higher mortality in combination than the product of the
mortality associated with the individual diagnosis groups.
On the contrary, cancer–mental, followed by gastro–cardi-
ovascular, had lower mortality in combination compared to
the product of the single diagnoses. To the best of our
knowledge, only one study has explored the interaction
effect of pairs of diagnoses included in multimorbidity on
mortality, finding excess mortality for combinations
including cancer,13 which is in contrast to our findings.
Although somewhat speculative, the high mortality con-
nected with the kidney–endocrine combination could be
an accumulation of diabetes patients who are worse off in
this combination compared to those in other combinations.
The lower excess mortality for the cancer–mental combi-
nation could be a result of better management of the men-
tally ill patients in general when they are diagnosed with a
somatic disease. It could also be explained by patients in
this group having cancers of lower stage.
In this study, mortality increased with the number of
diagnosis groups which is in line with other studies.12,18 The
combination of musculoskeletal, endocrine, mental, neuro-
logical, and cardiovascular had a 70 times increased mortal-
ity, compared with people not belonging to any of the
diagnosis groups, even after adjustment. The influence of
age and socioeconomic status on multimorbidity is well-
known.7,41 One study found increased mortality of 25%
when having three conditions, rising to 80% when having
five or more.19 Yet another study found a steep decline in
survival rates when having three conditions or more and
found people with zero, one, or two conditions having
largely equal remaining life expectancy.42 Other factors,
besides number and type of conditions,13 are shown to be
important for mortality, for example, perceived stress.34
Furthermore, socioeconomic status41 and disability22 have
been identified as important intermediate factors for
mortality.
Strengths and limitations
When defining multimorbidity, many studies use simple
counts of diseases.4,5 In the present study, multimorbidity
is defined by counting groups of diagnoses with similarities
in treatments and management in both primary and second-
ary health care. Therefore, when having multimorbidity
according to this definition, diagnoses representing differ-
ent parts of the health-care system are included, allowing
for an extra organizational aspect to be considered. We
believe this way of defining multimorbidity can better
grasp the complexity and burden of multimorbidity than
definitions resting on simple diagnosis counts.43 A major
strength of this study is the large nationwide cohort includ-
ing the whole adult Danish population. The size makes it
possible to explore not only combinations of two diagnosis
groups but also combinations of more groups. However,
even if the risk of selection bias and sampling error is low,
interpretation has to be cautious since we can expect highly
significant p-values for clinically less important associa-
tions.44 Despite the high validity of CRS,23 a total of
15,543 (0.4%) persons disappeared from the cohort without
further information. However, sensitivity analyses includ-
ing these individuals did not change the conclusions. The
information on multimorbidity was based on registry data
from 10 years before baseline to collect information on
both prevalent and incident diagnoses.44 Incident diagnoses
could potentially have another disease trajectory, with
higher mortality initially and prevalent diagnoses could
be at risk of being caught later in the disease course. The
primary argument for use of logistic regression analyses to
assess the associations between multimorbidity and mor-
tality is the independence between the prevalence of the
outcome and the OR. This makes ORs directly comparable
across the different diagnosis groups and furthermore
enables us to construct measures combining several ORs
such as the ROR.
Our study has further limitations. Our use of secondary
care data underestimates the true prevalence of multimor-
bidity as it is seen in primary care. However, in Denmark,
nationwide primary care register data are not available.
Moreover, the employed registries are relatively valid,24,25
and by using this data source, we only include diagnoses
with a certain gravity since the underlying condition lead to
a referral to secondary care. Even though we adjusted our
analyses for several important aspects of demography and
socioeconomy, residual confounding cannot be ruled out
since we were not able to get information on important
lifestyle factors. Finally, we have no information on sever-
ity of the included diagnoses.
Implications
To the best of our knowledge, this is the first time mortality
related to prevalent multimorbidity has been studied in an
entire adult population over such a long time period. Con-
sequently, this study adds clinically relevant patterns of
multimorbidity valuable to consider when organizing
health care and creating care plans to meet the demands
of patients with multimorbidity. Combined specialist clinic
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visits for persons having, for example, musculoskeletal–
cardiovascular and cardiovascular–lung combinations
could be included in such coordinated care plans. Some
diagnosis groups should create extra awareness, for exam-
ple, neurological and lung, because of the high mortality for
many of their combinations, and endocrine and cardiovas-
cular because of the excess mortality when in different
combinations compared to as singles.
Conclusions
The combination of cardiovascular and lung diagnoses was
both prevalent and conferred high mortality. Some pairs of
diagnosis groups had a higher mortality in combination
than the combined mortality of the individual diagnoses,
for example, kidney–endocrine, but generally combina-
tions did not increase mortality above that expected, that
is, were additive rather than synergistic. Mortality
increased with the number of included diagnoses.
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